NewsDesk @infectiousdiseasenews
A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells. While...
A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
Researchers analyzed nearly 130...
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have...
People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published...
By NewsDesk @infectiousdiseasenews
Testing for the SARS-CoV-2, the virus that causes coronavirus disease 2019, or COVID-19 is the main topic of many newscasts, opinion shows, States and their Governors...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
